Global CHA Network

CHA Medical Group

CHA Medical Group’s advanced stem cell technology

CHA Medical Group has filed the following patents related to stem cell and immunocyte research.

No	Patent Grants
21	[KR] Whitening cosmetic composition comprising embryonic stem cell-derived vascular angiogenic progenitor cells (Registration number 10-1146113)
20	[KR] Novel mirna from human mesenchymal stem cell (Registration number 10-1133559)
19	[KR] Process for differentiation of human embryonic stem cells to mesenchymal stem cells and medium for differentiation thereof (Registration number 10-1119464)
18	[KR] Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof (Registration number 10-1106020)
17	[KR] Process for preparing placenta-derived serum replacements and process for cultivation of adult stem cells using the same (Registration number 10-1092851)
16	[KR] Cell delivery system for the cell therapy comprising cells derived from embryonic stem cells (Registration number 10-1046158)
15	[KR] Therapeutic implant for wound-healing using human embryonic stem cell derived vascular angiogenic progenitor cells(hESC-VAPCs) and method thereof
14	[US] Methods for vitrification of human oocytes (Registration number 07947497)
13	[US] Process for isolating vascular endothelial cells from embryoid bodies differentiated from embryonc stem cells (Registration number 07919318)
12	[KR] Composition for preventing or treating ultraviolet-induced skin damage (Registration number 10-1026069)